To donate by check, phone, or other method, see our More Ways to Give page.
In this world, where everything and everyone is for sale, we must sustain independent media we can trust. If you believe independent journalism is critical to protecting democracy and the common good, please support Common Dreams this Giving Tuesday! We wouldn't exist without you.
A CVS pharmacist administers a Covid-19 vaccine in Huntington Park, California, on August 28, 2024.
"What's at stake is we are reverting back to a system where a person's financial ability to be able to pay will determine their ability to be healthy."
The latest coronavirus vaccine costs up to $200 for the roughly 25 million uninsured people in the U.S., due to the defunding of a federal program that previously covered the costs, The Washington Postreported Tuesday.
It's the "latest tear in the safety net" as pandemic-era programs wind down, the newspaper reported. Covid-19 vaccines were free for everyone in the U.S. in 2021 and 2022, per federal policy. However, in January, congressional Republicans negotiated a deal that rescinded $6.1 billion in emergency coronavirus relief funding, which killed the Bridge Access Program, launched in April 2023, that covered the cost for the uninsured.
The latest version of the Covid-19 vaccine was approved on August 22 and costs just over $200 for uninsured patients at CVS pharmacies in Nashville and St. Louis—examples cited by the Post.
Raynard Washington, head of the Mecklenburg County health department in North Carolina and chair of the Big Cities Health Coalition, said that vaccine manufacturers Moderna and Pfizer-BioNTech should lower their prices to make the shots more affordable for health agencies.
"What's at stake is we are reverting back to a system where a person's financial ability to be able to pay will determine their ability to be healthy," Washington said.
News of the lack of affordable access to the Covid-19 vaccine for uninsured people led to outrage on social media, with one X user asking "Is this the way to keep the rest of us safe?" and another declaring: "This makes me want to scream."
People covered by Medicare—which insures Americans over the age of 65—and Medicaid can still receive Covid-19 vaccines for free. But roughly 25 million people in the U.S. under the age of 65 are uninsured and left to pay the sky-high rates; people of color are disproportionately represented in the ranks of the uninsured.
Moderna, Pfizer, and BioNTech have profited off of the sale of the vaccines even though U.S. and European taxpayers heavily subsidized their development. The companies told the Post that free vaccines would be available through patient assistance programs, but provided no details.
The Center for Disease Control and Prevention (CDC) said it had identified $62 million to purchase Covid-19 vaccines for distribution to health agencies, but officials say that's a "sliver" of what's needed, the paper reported.
The Biden administration in its budget requests repeatedly tried to establish a Vaccines for Adults program aimed at providing shots, including Covid-19 boosters, to uninsured adults, but the efforts stalled in Congress. The proposal was based on a federal Vaccines for Children program that's been active since the 1990s.
The new Covid-19 vaccine is recommended for everyone 6 months of age or older. It includes a level of protection against the KP.2 variant that accounted for roughly one quarter of U.S. cases this summer.
The public health emergency for Covid-19 ended in May 2023 but the virus has killed tens of thousands of people in the U.S. since then and can cause long-term complications.
Common Dreams is powered by optimists who believe in the power of informed and engaged citizens to ignite and enact change to make the world a better place. We're hundreds of thousands strong, but every single supporter makes the difference. Your contribution supports this bold media model—free, independent, and dedicated to reporting the facts every day. Stand with us in the fight for economic equality, social justice, human rights, and a more sustainable future. As a people-powered nonprofit news outlet, we cover the issues the corporate media never will. |
The latest coronavirus vaccine costs up to $200 for the roughly 25 million uninsured people in the U.S., due to the defunding of a federal program that previously covered the costs, The Washington Postreported Tuesday.
It's the "latest tear in the safety net" as pandemic-era programs wind down, the newspaper reported. Covid-19 vaccines were free for everyone in the U.S. in 2021 and 2022, per federal policy. However, in January, congressional Republicans negotiated a deal that rescinded $6.1 billion in emergency coronavirus relief funding, which killed the Bridge Access Program, launched in April 2023, that covered the cost for the uninsured.
The latest version of the Covid-19 vaccine was approved on August 22 and costs just over $200 for uninsured patients at CVS pharmacies in Nashville and St. Louis—examples cited by the Post.
Raynard Washington, head of the Mecklenburg County health department in North Carolina and chair of the Big Cities Health Coalition, said that vaccine manufacturers Moderna and Pfizer-BioNTech should lower their prices to make the shots more affordable for health agencies.
"What's at stake is we are reverting back to a system where a person's financial ability to be able to pay will determine their ability to be healthy," Washington said.
News of the lack of affordable access to the Covid-19 vaccine for uninsured people led to outrage on social media, with one X user asking "Is this the way to keep the rest of us safe?" and another declaring: "This makes me want to scream."
People covered by Medicare—which insures Americans over the age of 65—and Medicaid can still receive Covid-19 vaccines for free. But roughly 25 million people in the U.S. under the age of 65 are uninsured and left to pay the sky-high rates; people of color are disproportionately represented in the ranks of the uninsured.
Moderna, Pfizer, and BioNTech have profited off of the sale of the vaccines even though U.S. and European taxpayers heavily subsidized their development. The companies told the Post that free vaccines would be available through patient assistance programs, but provided no details.
The Center for Disease Control and Prevention (CDC) said it had identified $62 million to purchase Covid-19 vaccines for distribution to health agencies, but officials say that's a "sliver" of what's needed, the paper reported.
The Biden administration in its budget requests repeatedly tried to establish a Vaccines for Adults program aimed at providing shots, including Covid-19 boosters, to uninsured adults, but the efforts stalled in Congress. The proposal was based on a federal Vaccines for Children program that's been active since the 1990s.
The new Covid-19 vaccine is recommended for everyone 6 months of age or older. It includes a level of protection against the KP.2 variant that accounted for roughly one quarter of U.S. cases this summer.
The public health emergency for Covid-19 ended in May 2023 but the virus has killed tens of thousands of people in the U.S. since then and can cause long-term complications.
The latest coronavirus vaccine costs up to $200 for the roughly 25 million uninsured people in the U.S., due to the defunding of a federal program that previously covered the costs, The Washington Postreported Tuesday.
It's the "latest tear in the safety net" as pandemic-era programs wind down, the newspaper reported. Covid-19 vaccines were free for everyone in the U.S. in 2021 and 2022, per federal policy. However, in January, congressional Republicans negotiated a deal that rescinded $6.1 billion in emergency coronavirus relief funding, which killed the Bridge Access Program, launched in April 2023, that covered the cost for the uninsured.
The latest version of the Covid-19 vaccine was approved on August 22 and costs just over $200 for uninsured patients at CVS pharmacies in Nashville and St. Louis—examples cited by the Post.
Raynard Washington, head of the Mecklenburg County health department in North Carolina and chair of the Big Cities Health Coalition, said that vaccine manufacturers Moderna and Pfizer-BioNTech should lower their prices to make the shots more affordable for health agencies.
"What's at stake is we are reverting back to a system where a person's financial ability to be able to pay will determine their ability to be healthy," Washington said.
News of the lack of affordable access to the Covid-19 vaccine for uninsured people led to outrage on social media, with one X user asking "Is this the way to keep the rest of us safe?" and another declaring: "This makes me want to scream."
People covered by Medicare—which insures Americans over the age of 65—and Medicaid can still receive Covid-19 vaccines for free. But roughly 25 million people in the U.S. under the age of 65 are uninsured and left to pay the sky-high rates; people of color are disproportionately represented in the ranks of the uninsured.
Moderna, Pfizer, and BioNTech have profited off of the sale of the vaccines even though U.S. and European taxpayers heavily subsidized their development. The companies told the Post that free vaccines would be available through patient assistance programs, but provided no details.
The Center for Disease Control and Prevention (CDC) said it had identified $62 million to purchase Covid-19 vaccines for distribution to health agencies, but officials say that's a "sliver" of what's needed, the paper reported.
The Biden administration in its budget requests repeatedly tried to establish a Vaccines for Adults program aimed at providing shots, including Covid-19 boosters, to uninsured adults, but the efforts stalled in Congress. The proposal was based on a federal Vaccines for Children program that's been active since the 1990s.
The new Covid-19 vaccine is recommended for everyone 6 months of age or older. It includes a level of protection against the KP.2 variant that accounted for roughly one quarter of U.S. cases this summer.
The public health emergency for Covid-19 ended in May 2023 but the virus has killed tens of thousands of people in the U.S. since then and can cause long-term complications.